| [1] |
CHANG ML, YANG SS. Metabolic signature of hepatic fibrosis: From individual pathways to systems biology[J]. Cells, 2019, 8( 11): 1423. DOI: 10.3390/cells8111423. |
| [2] |
Liver Disease Committee, Chinese Association of Integrative Medicine. Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice(2019)[J]. J Clin Hepatol, 2019, 35( 7): 1444- 1449. DOI: 10.3969/j.issn.1001-5256.2019.07.007. |
| [3] |
LI YW, LU YR, NIAN MZ, et al. Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease[J]. Chin J Nat Med, 2023, 21( 9): 643- 657. DOI: 10.1016/S1875-5364(23)60443-1. |
| [4] |
DAWOOD RM, EL-MEGUID MA, SALUM GM, et al. Key players of hepatic fibrosis[J]. J Interferon Cytokine Res, 2020, 40( 10): 472- 489. DOI: 10.1089/jir.2020.0059. |
| [5] |
KIM HY, SAKANE S, EGUILEOR A, et al. The origin and fate of liver myofibroblasts[J]. Cell Mol Gastroenterol Hepatol, 2024, 17( 1): 93- 106. DOI: 10.1016/j.jcmgh.2023.09.008. |
| [6] |
DEL CAMPO JA, GALLEGO P, GRANDE L. Role of inflammatory response in liver diseases: Therapeutic strategies[J]. World J Hepatol, 2018, 10( 1): 1- 7. DOI: 10.4254/wjh.v10.i1.1. |
| [7] |
SUN MX, KISSELEVA T. Reversibility of liver fibrosis[J]. Clin Res Hepatol Gastroenterol, 2015, 39( Suppl 1): S60- S63. DOI: 10.1016/j.clinre.2015.06.015. |
| [8] |
SHAN L, LIU ZN, CI LL, et al. Research progress on the anti-hepatic fibrosis action and mechanism of natural products[J]. Int Immunopharmacol, 2019, 75: 105765. DOI: 10.1016/j.intimp.2019.105765. |
| [9] |
KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18( 3): 151- 166. DOI: 10.1038/s41575-020-00372-7. |
| [10] |
SIMBRUNNER B, VILLESEN IF, KÖNIGSHOFER P, et al. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease[J]. Liver Int, 2022, 42( 11): 2501- 2512. DOI: 10.1111/liv.15365. |
| [11] |
ZHAO HW, ZHANG ZF, CHAI X, et al. Oxymatrine attenuates CCl 4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways[J]. Int Immunopharmacol, 2016, 36: 249- 255. DOI: 10.1016/j.intimp.2016.04.040. |
| [12] |
ZHANG JB, JIN HL, FENG XY, et al. The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis[J]. Front Pharmacol, 2022, 13: 984611. DOI: 10.3389/fphar.2022.984611. |
| [13] |
SHANG X, YUAN H, DAI L, et al. Anti-liver fibrosis activity and the potential mode of action of Ruangan Granules: Integrated network pharmacology and metabolomics[J]. Front Pharmacol, 2021, 12: 754807. DOI: 10.3389/fphar.2021.754807. |
| [14] |
KIM HY, CHOI YJ, KIM SK, et al. Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome[J]. Commun Biol, 2021, 4( 1): 824. DOI: 10.1038/s42003-021-02345-1. |
| [15] |
WANG XM, CUI YQ, WANG J, et al. Liuwei Dihuang pills attenuates liver fibrosis by inhibiting macrophage activation in CCl 4 induced liver injury[J]. J Nanjing Univ Tradit Chin Med, 2017, 33( 1): 65- 68. DOI: 10.14148/j.issn.1672-0482.2016.0065. |
| [16] |
LI Z, ZHU JF, OUYANG H. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress[J]. World J Hepatol, 2023, 15( 10): 1091- 1108. DOI: 10.4254/wjh.v15.i10.1091. |
| [17] |
YU HY, JIANG X, DONG FY, et al. Lipid accumulation-induced hepatocyte senescence regulates the activation of hepatic stellate cells through the Nrf2-antioxidant response element pathway[J]. Exp Cell Res, 2021, 405( 2): 112689. DOI: 10.1016/j.yexcr.2021.112689. |
| [18] |
DHAR D, BAGLIERI J, KISSELEVA T, et al. Mechanisms of liver fibrosis and its role in liver cancer[J]. Exp Biol Med(Maywood), 2020, 245( 2): 96- 108. DOI: 10.1177/1535370219898141. |
| [19] |
KONG R, WANG N, LUO H, et al. Hesperetin Mitigates bile duct ligation-induced liver fibrosis by inhibiting extracellular matrix and cell apoptosis via the TGF-β1/Smad pathway[J]. Curr Mol Med, 2018, 18( 1): 15- 24. DOI: 10.2174/1566524018666180608084947. |
| [20] |
MIAO Y, WU YL, JIN YJ, et al. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice[J]. Chem Biol Interact, 2020, 317: 108945. DOI: 10.1016/j.cbi.2020.108945. |
| [21] |
WU TH, WANG PW, LIN TY, et al. Antioxidant properties of red raspberry extract alleviate hepatic fibrosis via inducing apoptosis and transdifferentiation of activated hepatic stellate cells[J]. Biomed Pharmacother, 2021, 144: 112284. DOI: 10.1016/j.biopha.2021.112284. |
| [22] |
GUO YJ, LIANG XM, MENG MY, et al. Hepatoprotective effects of Yulangsan flavone against carbon tetrachloride(CCl 4)-induced hepatic fibrosis in rats[J]. Phytomedicine, 2017, 33: 28- 35. DOI: 10.1016/j.phymed.2017.07.005. |
| [23] |
JANGRA A, KOTHARI A, SARMA P, et al. Recent advancements in antifibrotic therapies for regression of liver fibrosis[J]. Cells, 2022, 11( 9): 1500. DOI: 10.3390/cells11091500. |
| [24] |
WANG Q, DAI XF, YANG WZ, et al. Caffeine protects against alcohol-induced liver fibrosis by dampening the cAMP/PKA/CREB pathway in rat hepatic stellate cells[J]. Int Immunopharmacol, 2015, 25( 2): 340- 352. DOI: 10.1016/j.intimp.2015.02.012. |
| [25] |
BAI FC, HUANG QF, NIE JL, et al. Trolline ameliorates liver fibrosis by inhibiting the NF-κB pathway, promoting HSC apoptosis and suppressing autophagy[J]. Cell Physiol Biochem, 2017, 44( 2): 436- 446. DOI: 10.1159/000485009. |
| [26] |
WANG JH, GUO XH, ZHENG BW, et al. Mechanism of curcumol against liver fibrosis based on miR-125b/NLRP3 signaling pathway[J]. Chin Arch Tradit Chin Med, 2022, 40( 11): 95- 99. DOI: 10.13193/j.issn.1673-7717.2022.11.023. |
| [27] |
XING XR. Multi-target based mechansim investigation of Fuzheng Huayu Formula in treating liver fibrosis[D]. Shanghai: Naval Medical University, 2019.
邢心睿. 扶正化瘀方抗肝纤维化的网络多靶标作用机制研究[D]. 上海: 中国人民解放军海军军医大学, 2019.
|
| [28] |
SUN X, PING DB, PENG Y, et al. Fuzheng Huayu Fang enhances the anti-liver fibrosis mechanism of action of NK cells to kill and activate liver stellate cells[C]// Proceedings of the Thirteenth National Academic Conference on Integrated Traditional Chinese Medicine and Western Medicine for Digestive System Diseases. 2019: 274- 275. DOI: 10.26914/c.cnkihy.2019.016545. |
| [29] |
ACHARYA P, CHOUHAN K, WEISKIRCHEN S, et al. Cellular mechanisms of liver fibrosis[J]. Front Pharmacol, 2021, 12: 671640. DOI: 10.3389/fphar.2021.671640. |
| [30] |
LIN YC, LUO HY, WANG X, et al. Flavanones from Sedum sarmentosum bunge alleviate CCl 4-induced liver fibrosis in rats by targeting TGF-β1/TβR/smad pathway in turn inhibiting epithelial mesenchymal transition[J]. Evid Based Complement Alternat Med, 2018, 2018: 3080837. DOI: 10.1155/2018/3080837. |
| [31] |
ZHANG GK, JIANG YY, LIU X, et al. Lingonberry anthocyanins inhibit hepatic stellate cell activation and liver fibrosis via TGFβ/smad/ERK signaling pathway[J]. J Agric Food Chem, 2021, 69( 45): 13546- 13556. DOI: 10.1021/acs.jafc.1c05384. |
| [32] |
SHENG JP, ZHANG BH, CHEN YF, et al. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages[J]. Immunopharmacol Immunotoxicol, 2020, 42( 6): 556- 563. DOI: 10.1080/08923973.2020.1811308. |
| [33] |
HUANG Y, XIA L, LEI QS, et al. Protective effects and mechanism of saikosaponin D on immune hepatic fibrosis in rats[J]. J Army Med Univ, 2022, 44( 14): 1410- 1420. DOI: 10.16016/j.2097-0927.202111062. |
| [34] |
KHURANA A, SAYED N, ALLAWADHI P, et al. It’s all about the spaces between cells: Role of extracellular matrix in liver fibrosis[J]. Ann Transl Med, 2021, 9( 8): 728. DOI: 10.21037/atm-20-2948. |
| [35] |
MENGGENSILIMU, YUAN HW, ZHAO CM, et al. Anti-liver fibrosis effect of total flavonoids from Scabiosa comosa Fisch. ex Roem. et Schult. on liver fibrosis in rat models and its proteomics analysis[J]. Ann Palliat Med, 2020, 9( 2): 272- 285. DOI: 10.21037/apm.2020.02.29. |
| [36] |
LI Q, WU HC, TAN JX, et al. Study on machanism of Rougan Formula in anti-hepatic fibrosis by inhibiting fibrosin[J]. Chin J Immunol, 2022, 38( 3): 263- 269. DOI: 10.3969/j.issn.1000-484X.2022.03.002. |
| [37] |
LI ZB, JIANG L, NI JD, et al. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells[J]. Acta Pharmacol Sin, 2023, 44( 6): 1191- 1205. DOI: 10.1038/s41401-022-01044-9. |
| [38] |
WU HY, GU YQ, ZHOU HC, et al. Effects of cycloastragenol on carbon tetrachloride-induced hepatic fibrosis and glycolysis in mice[J]. China Pharm, 2022, 33( 14): 1677- 1681, 1687. DOI: 10.6039/j.issn.1001-0408.2022.14.03. |
| [39] |
GUO T, LIU ZL, ZHAO Q, et al. A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo[J]. Acta Pharmacol Sin, 2018, 39( 9): 1483- 1492. DOI: 10.1038/aps.2017.175. |
| [40] |
SUN X, TAN Y, LYU J, et al. Active components formulation developed from Fuzheng Huayu Recipe for anti-liver fibrosis[J]. Chin J Integr Med, 2022, 28( 6): 538- 544. DOI: 10.1007/s11655-021-3293-x. |
DownLoad: